云南白药
(000538)
| 流通市值：911.51亿 | | | 总市值：911.58亿 |
| 流通股本：17.84亿 | | | 总股本：17.84亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 9,569,904,053.5 | 9,222,540,388.69 | 9,107,829,167.98 | 8,617,685,450.33 |
| 交易性金融资产 | 4,751,169,278.18 | 4,795,948,348.48 | 4,192,113,408.43 | 4,469,452,687.43 |
| 应收票据及应收账款 | 10,808,802,157.24 | 12,508,877,781.45 | 10,745,425,434.22 | 10,897,400,719.22 |
| 其中：应收票据 | 626,199,670.96 | 589,669,195.05 | 585,366,210.93 | 641,767,683.41 |
| 应收账款 | 10,182,602,486.28 | 11,919,208,586.4 | 10,160,059,223.29 | 10,255,633,035.81 |
| 应收款项融资 | 838,621,388.17 | 1,338,060,523.81 | 1,681,985,583.93 | 1,759,204,501.36 |
| 预付款项 | 337,934,281.51 | 289,889,068.24 | 434,442,949.73 | 271,587,944.61 |
| 其他应收款合计 | 632,395,561.18 | 422,316,792.24 | 406,517,244.11 | 213,585,502.86 |
| 应收股利 | 232,969,378.6 | - | 79,875,215.52 | - |
| 存货 | 6,147,877,228.16 | 6,155,429,415.3 | 6,231,383,826.69 | 5,777,215,651.87 |
| 一年内到期的非流动资产 | - | - | - | 491,314,305.56 |
| 其他流动资产 | 1,181,461,092.17 | 1,187,470,265.58 | 1,234,895,158.04 | 1,275,971,266.65 |
| 流动资产合计 | 34,268,165,040.11 | 35,920,532,583.79 | 34,034,592,773.13 | 33,776,781,451.64 |
| 非流动资产: | | | | |
| 长期股权投资 | 13,648,237,691.06 | 13,468,526,509.92 | 13,227,578,051.91 | 13,272,819,669.4 |
| 其他权益工具投资 | 71,745,000 | 71,745,000 | 71,745,000 | 71,745,000 |
| 其他非流动金融资产 | 312,435,493.34 | 211,218,546.82 | 210,855,260.47 | 206,201,265.68 |
| 投资性房地产 | 46,995,322.73 | 48,685,675.45 | 50,366,578.65 | 49,791,991.7 |
| 固定资产 | 3,212,622,675.46 | 3,239,654,959.49 | 3,274,340,152.34 | 3,014,879,748.98 |
| 在建工程 | 932,187,206.75 | 868,938,372.7 | 807,592,848.36 | 812,782,573.35 |
| 生产性生物资产 | 558,674.79 | 601,649.82 | 644,624.85 | 687,599.76 |
| 使用权资产 | 231,636,423.58 | 241,158,714.85 | 248,003,380.85 | 283,832,702.81 |
| 无形资产 | 683,001,612.22 | 689,953,911.25 | 699,193,405.35 | 546,038,401.83 |
| 开发支出 | 125,163,486.09 | 105,348,090.53 | 98,211,219.56 | 61,236,117.43 |
| 商誉 | 300,805,632.99 | 300,805,632.99 | 300,805,632.99 | 96,963,241.17 |
| 长期待摊费用 | 119,477,510.15 | 125,244,210.77 | 108,871,585 | 97,841,031.74 |
| 递延所得税资产 | 1,021,868,341.03 | 993,806,443.65 | 974,220,393.56 | 887,515,635.2 |
| 其他非流动资产 | 170,369,539.17 | 171,008,175.64 | 161,560,224.8 | 164,368,290.7 |
| 非流动资产合计 | 20,877,104,609.36 | 20,536,695,893.88 | 20,233,988,358.69 | 19,566,703,269.75 |
| 资产总计 | 55,145,269,649.47 | 56,457,228,477.67 | 54,268,581,131.82 | 53,343,484,721.39 |
| 流动负债: | | | | |
| 短期借款 | 25,113,604.1 | 24,821,993.14 | 182,775,753.21 | 8,309,937.06 |
| 应付票据及应付账款 | 7,387,327,513.45 | 7,659,029,686.56 | 7,369,736,332.47 | 6,699,231,552.75 |
| 其中：应付票据 | 1,668,214,258.64 | 1,875,012,474.5 | 1,846,714,475.61 | 1,868,792,908.71 |
| 应付账款 | 5,719,113,254.81 | 5,784,017,212.06 | 5,523,021,856.86 | 4,830,438,644.04 |
| 预收款项 | 518,138.91 | 803,512.88 | 190,841.21 | 763,060.22 |
| 合同负债 | 1,578,687,785.93 | 1,598,214,521.91 | 1,505,826,938.18 | 2,073,196,426.02 |
| 应付职工薪酬 | 1,234,856,594.21 | 1,108,834,527.97 | 1,482,601,305.72 | 1,022,602,162.11 |
| 应交税费 | 578,166,281.56 | 527,824,239.7 | 278,051,492.11 | 375,622,520.94 |
| 其他应付款合计 | 1,378,906,340.85 | 1,402,594,780.01 | 1,461,459,334.99 | 1,372,376,644.43 |
| 应付股利 | 1,317,388.73 | 1,317,388.73 | 1,317,388.73 | 3,343,293.66 |
| 一年内到期的非流动负债 | 164,848,943.89 | 80,245,778.63 | 76,443,711.53 | 92,360,379.69 |
| 其他流动负债 | 637,544,159.21 | 697,119,681.01 | 533,163,346.13 | 721,861,278.49 |
| 流动负债合计 | 12,985,969,362.11 | 13,099,488,721.81 | 12,890,249,055.55 | 12,366,323,961.71 |
| 非流动负债: | | | | |
| 长期借款 | 2,100,000 | 86,569,400.83 | 86,569,400.83 | 2,100,000 |
| 租赁负债 | 133,099,612.83 | 131,687,547.44 | 141,830,379.18 | 183,821,849.68 |
| 长期应付款 | 535,500,453.36 | 546,234,412.72 | 556,079,941.48 | 570,453,986.59 |
| 长期应付职工薪酬 | 1,598,405.18 | 1,654,905.75 | 1,718,946.33 | 1,157,914.72 |
| 预计负债 | 32,255,978.72 | 25,201,996.3 | 22,513,696.41 | 22,242,422.01 |
| 递延收益 | 240,714,191.91 | 242,873,654.35 | 271,769,812.59 | 249,184,460.19 |
| 递延所得税负债 | 164,130,283.73 | 151,942,865.07 | 148,417,516.74 | 128,394,961.52 |
| 其他非流动负债 | 1,931,554.36 | 1,931,554.36 | 1,931,554.36 | 1,931,554.36 |
| 非流动负债合计 | 1,111,330,480.09 | 1,188,096,336.82 | 1,230,831,247.92 | 1,159,287,149.07 |
| 负债合计 | 14,097,299,842.2 | 14,287,585,058.63 | 14,121,080,303.47 | 13,525,611,110.78 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,784,262,603 | 1,784,262,603 | 1,784,262,603 | 1,784,262,603 |
| 资本公积 | 17,697,085,699.03 | 17,654,206,638.34 | 17,632,117,190.85 | 17,692,211,761.57 |
| 其他综合收益 | -117,648,883.03 | -112,057,243 | -105,091,380.51 | -99,474,924.21 |
| 盈余公积 | 2,530,458,968.58 | 2,530,458,968.58 | 2,530,458,968.58 | 2,530,458,968.58 |
| 未分配利润 | 19,078,994,395.52 | 20,239,618,452.65 | 18,202,311,462.52 | 17,825,944,281.08 |
| 归属于母公司股东权益合计 | 40,973,152,783.1 | 42,096,489,419.57 | 40,044,058,844.44 | 39,733,402,690.02 |
| 少数股东权益 | 74,817,024.17 | 73,153,999.47 | 103,441,983.91 | 84,470,920.59 |
| 股东权益合计 | 41,047,969,807.27 | 42,169,643,419.04 | 40,147,500,828.35 | 39,817,873,610.61 |
| 负债和股东权益合计 | 55,145,269,649.47 | 56,457,228,477.67 | 54,268,581,131.82 | 53,343,484,721.39 |
| 公告日期 | 2026-08-29 | 2026-04-30 | 2026-04-01 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |